GlassScriptPhysician profile
Vincenza E Mineo
NPI 1487947537
$2,065.59
in general payments reported to CMS, 2019-2025
17 companies · $631 in 2025
The $631 reported for 2025 was more than what a typical Podiatrist provider received nationally (typical 2025 total: $260).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $488 · 2020: $110 · 2021: $16.50 · 2023: $372 · 2024: $448 · 2025: $631.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,451.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,451.34 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Stryker Corporation | $807.11 | 2023-2025 | Hoffmann, Na, Pangea |
| Ortho Dermatologics, A Division of Bausch Health US, LLC | $355.46 | 2019-2025 | Jublia |
| Integra Lifesciences Corporation | $173.27 | 2025 | Integra, Primatrix, Integra Dermal Regeneration Template |
| Kerecis Limited | $151.55 | 2025 | Kerecis Surgiclose, Kerecis Graftguide |
| Horizon Therapeutics Plc | $135.09 | 2019 | |
| Organogenesis INC. | $124.37 | 2019 | |
| Melinta Therapeutics, LLC | $99.67 | 2019 | |
| Paratek Pharmaceuticals, INC. | $39.12 | 2024-2025 | Nuzyra |
| Solventum Corporation | $34.16 | 2024 | V.A.C.Ulta, V.A.C. Veraflo, V.A.C. Veraflo Cleanse Choice |
| Convatec INC. | $27.89 | 2023 | |
| Zimmer Biomet Holdings, INC. | $21.98 | 2019 | |
| Hydrofera LLC | $21.64 | 2025 | Hydrofera Blue |
| Abbvie INC. | $16.60 | 2023 | |
| Bioventus LLC | $16.50 | 2021 | |
| Treace Medical Concepts, INC. | $14.32 | 2024 |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Arthrosurface Incorporated | $13.43 | 2020 | |
| Merck Sharp & Dohme LLC | $13.43 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Vincenza Mineo listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.